"It's important to note that these Healthy Choice products weren't made specifically for GLP-1 users they're just being badged as appropriate for GLP-1 users," says Alexandra Sowa, MD, an internal medicine doctor specializing in preventative health, nutrition, and obesity medicine and the author of the forthcoming book The Ozempic Revolution
Beyond-use date testing
A Phase 2 clinical trial published in the New England Journal of Medicine in 2023 reported mean body weight reductions of approximately 24% at 48 weeks at the highest studied dose
The glucagon component can transiently raise blood glucose before the GLP-1 and GIP components bring it back down
Blood tests may show increased bilirubin, alkaline phosphatase, GGT, ALT, AST, or white blood cells when biliary obstruction or inflammation is present
Retatrutide has demonstrated a generally favorable safety profile across Phase 2 and Phase 3 clinical trials